Gjb2 gene therapy(Takara Bio)

N/A

Report date: 2024/07/03 15:08:45

Base Information

Drug NameGjb2 gene therapy(Takara Bio)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGap junction beta-2 protein gene transference
TargetsGap junction beta-2 protein
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakara Bio IncGap Junction Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGap Junction Therapeutics IncTakara Bio Inc
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A